(redirected from Ocular hypertension)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to Ocular hypertension: glaucoma, ocular migraine
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for hypertension

a common disorder in which blood pressure remains abnormally high (a reading of 140/90 mm Hg or greater)

References in periodicals archive ?
Comparative efficacy and safety of the fixed versus unfixed combination of latanoprost and timolol in Chinese patients with open-angle glaucoma or ocular hypertension.
One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension.
A review of the Ocular Hypertension products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
So, undergo regular eye exams to identify ocular hypertension and to diagnose glaucoma early on, to minimize damage to the optic nerve and vision loss.
The aim of this study was to check whether steroids can be used to induce experimental glaucoma / ocular hypertension in an animal model.
This report describes a case of ocular hypertension in a western screech owl.
Via topical administration, VYZULTA, which the first prostaglandin analog with one of its metabolites being nitric oxide (NO), is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Ocular Hypertension is defined as an IOP of 21mmHg or greater, normal visual fields, normal optic disc, open angles and absence of any ocular or systemic disorders contributing to the elevated IOP.
Provision of Consultant first assessments for patients with chronic open angle glaucoma (COAG) and ocular hypertension (OHT) diagnosis and monitoring service.
4'7] But, there is a dearth of literature related to BMI, BP, and their effects on IOP in children of patients with hypertension, which could help us in predicting the future onset of ocular hypertension (glaucoma).
Ocular Hypertension - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
BAUSCH + LOMB (B+L) has confirmed that it will push forward with phase III of a clinical trial of latanoprostene bunod in the reduction of intraocular pressure (IOP) for patients with glaucoma or ocular hypertension.
A Ocular hypertension is the term referring to increased pressure in your eyes.
Initially, the pilot will provide the mechanism for patients with stable glaucoma or ocular hypertension to be followed up in the community, close to home.
Scientists at Sami Labs have developed a stable formulation of forskolin eye drops for use in the management of ocular hypertension and glaucoma.